YU35785B - Process for obtaining a live virus vaccine against marek disease - Google Patents

Process for obtaining a live virus vaccine against marek disease

Info

Publication number
YU35785B
YU35785B YU625/71A YU62571A YU35785B YU 35785 B YU35785 B YU 35785B YU 625/71 A YU625/71 A YU 625/71A YU 62571 A YU62571 A YU 62571A YU 35785 B YU35785 B YU 35785B
Authority
YU
Yugoslavia
Prior art keywords
obtaining
vaccine against
virus vaccine
live virus
against marek
Prior art date
Application number
YU625/71A
Other languages
English (en)
Other versions
YU62571A (en
Inventor
Okazaki William
William Okazaki
Purchase Harvey Graham
Harvey Graham Purchase
Witter Richard Lawrence
Richard Lawrence Witter
Original Assignee
Merck & Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck & Co Inc filed Critical Merck & Co Inc
Publication of YU62571A publication Critical patent/YU62571A/xx
Publication of YU35785B publication Critical patent/YU35785B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/245—Herpetoviridae, e.g. herpes simplex virus
    • A61K39/255—Marek's disease virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5254—Virus avirulent or attenuated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/16011—Herpesviridae
    • C12N2710/16311—Mardivirus, e.g. Gallid herpesvirus 2, Marek-like viruses, turkey HV
    • C12N2710/16334—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Zoology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
YU625/71A 1970-04-29 1971-03-12 Process for obtaining a live virus vaccine against marek disease YU35785B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US3306070A 1970-04-29 1970-04-29

Publications (2)

Publication Number Publication Date
YU62571A YU62571A (en) 1980-10-31
YU35785B true YU35785B (en) 1981-06-30

Family

ID=21868356

Family Applications (1)

Application Number Title Priority Date Filing Date
YU625/71A YU35785B (en) 1970-04-29 1971-03-12 Process for obtaining a live virus vaccine against marek disease

Country Status (21)

Country Link
US (1) US3642574A (de)
JP (1) JPS4841534B1 (de)
AT (2) AT317421B (de)
BE (1) BE766492A (de)
BR (1) BR7102066D0 (de)
CA (1) CA934295A (de)
CH (1) CH565863A5 (de)
CS (1) CS191868B2 (de)
DE (1) DE2120929B2 (de)
DK (1) DK133311C (de)
ES (1) ES390698A1 (de)
FR (1) FR2092112B1 (de)
GB (2) GB1316168A (de)
HU (1) HU162835B (de)
IE (1) IE35138B1 (de)
IL (1) IL36329A (de)
IT (1) IT1045525B (de)
NL (1) NL165217C (de)
PL (1) PL76295B1 (de)
YU (1) YU35785B (de)
ZA (1) ZA711382B (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3915794A (en) * 1973-02-09 1975-10-28 Rit Rech Ind Therapeut Stabilizing compositions for cell-free viruses and cell-free virus preparations containing them
US3981771A (en) * 1973-07-19 1976-09-21 Martin Sevoian Marek's disease vaccine
US3965258A (en) * 1974-11-30 1976-06-22 Merck & Co., Inc. Process for production of vaccines
US4160024A (en) * 1978-05-01 1979-07-03 Cornell Research Foundation, Inc. Marek's disease vaccine
US4309416A (en) * 1979-09-20 1982-01-05 Research Corporation Vaccines from taxonomically similar organisms
NL8401120A (nl) * 1984-04-09 1985-11-01 Centraal Diergeneeskundig Inst Viruspreparaat, waarmee gevaccineerd kan worden tegen de ziekte van marek.
HU197517B (en) * 1984-07-30 1989-04-28 Laszlo Csatary Process for production of terapeutical composition applicable against virus infection
JPS6327437A (ja) * 1986-07-17 1988-02-05 Chemo Sero Therapeut Res Inst 鶏伝染病生ワクチン
US5582829A (en) * 1990-04-05 1996-12-10 Rx Technologies, Inc. Sonicated borrelia burgdorferi vaccine
US6303129B1 (en) 1992-07-28 2001-10-16 Rx Technologies Production of borrelia burgdorferi vaccine, product produced thereby and method of use
WO2010008528A2 (en) * 2008-07-18 2010-01-21 The Texas A&M University System Marek's disease virus vaccine compositions and methods of using thereof
EP3326646A1 (de) 2012-03-22 2018-05-30 Merial, Inc. Modifiziertes marek-krankheitsvirus und daraus hergestellte impfstoffe

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1292803A (en) * 1968-11-18 1972-10-11 Nat Res Dev Improvements relating to the production of antigens

Also Published As

Publication number Publication date
HU162835B (de) 1973-04-28
AT317606B (de) 1974-09-10
BE766492A (fr) 1971-09-16
ES390698A1 (es) 1973-07-01
IE35138B1 (en) 1975-11-26
PL76295B1 (de) 1975-02-28
FR2092112A1 (de) 1972-01-21
JPS4841534B1 (de) 1973-12-07
NL165217B (nl) 1980-10-15
US3642574A (en) 1972-02-15
DE2120929B2 (de) 1979-06-28
ZA711382B (en) 1972-11-29
GB1317710A (en) 1973-05-23
IE35138L (en) 1971-10-29
FR2092112B1 (de) 1974-09-06
DK133311C (da) 1976-09-20
CS191868B2 (en) 1979-07-31
IL36329A0 (en) 1971-05-26
DK133311B (da) 1976-04-26
AT317421B (de) 1974-08-26
NL165217C (nl) 1981-03-16
IL36329A (en) 1975-04-25
CH565863A5 (de) 1975-08-29
GB1316168A (en) 1973-05-09
IT1045525B (it) 1980-05-10
YU62571A (en) 1980-10-31
DE2120929A1 (de) 1971-11-18
NL7100529A (de) 1971-11-02
CA934295A (en) 1973-09-25
BR7102066D0 (pt) 1973-03-13

Similar Documents

Publication Publication Date Title
YU35785B (en) Process for obtaining a live virus vaccine against marek disease
YU328073A (en) Process for obtaining a live vaccine of the virus of infectious bovine rhinotracheitis
ZA755043B (en) Enteric disease vaccine
NL169031B (nl) Werkwijze ter bereiding van een vaccin.
IL37682A (en) Process for the manufacture of a live vaccine against the infectious bursitis of chickens
IL29925A0 (en) Tetanus vaccine and process for preparing it
NL170595C (nl) Werkwijze ter bereiding van een vaccin tegen newcastle-ziekte.
CA955850A (en) Process for preparing live virus vaccines
IE35695L (en) Virus preparation
BE771536A (fr) Preparation d'un vaccin
AU476149B2 (en) Process for preparing live virus vaccines
AU2793871A (en) Process for preparing live virus vaccines
BE769619A (fr) Procede de preparation d'un pyroglutamylpeptide
YU33692B (en) Process for preparing a foot-and-mouth disease vaccine
ZA695453B (en) Multivalent live vaccine
AU463823B2 (en) Method forthe production ofa killed or live virus vaccine
IE35139B1 (en) Poultry vaccine
HU172178B (hu) Sposob poluchenija vakciny protiv bolezni mareka
NL171777C (nl) Werkwijze ter bereiding van een vaccin van rubellavirus.
FI41590C (fi) Menetelmä elävän rokotteen valmistamiseksi suu- ja sorkkatautia vastaan
IL27927A (en) Process for cultivating foot and mouth disease virus
AU2625371A (en) Poultry vaccine
AU2793971A (en) Marek's disease inactivated vaccine and process for preparing the same
NL171123C (nl) Werkwijze ter bereiding van een sterk verzwakt vaccin van rubellavirus.
IE35826L (en) Infectious bovine rhinotracheitis virus vaccine.